Diabetes is marked by delayed wound healing response and prolonged phase of inflammation. 28 Toll-like receptors (TLRs) are the key pathogen recognition receptors known to regulate 29 inflammation in wound healing. Therefore, we aim to investigate the role of TLRs in delayed 30 healing of diabetic wounds. TLR (1-9) expression studies were conducted using J774 macrophage 31 cell line. Further, primary macrophages were isolated from wound tissues of db/db mice, subjected 32 to RT-PCR and western blot analysis. The RT-PCR expression of TLRs revealed that expression 33 of TLR2, TLR4, TLR5, TLR6, TLR7 and TLR8 were significantly upregulated in macrophage 34 cells, cultured in high glucose medium. Expression of TLR 1-9 were significantly upregulated in 35 wound tissues of db/db mice. However, TLR1, TLR2 and TLR4, TLR6, TLR7 were only found 36 upregulated in the primary macrophages. Only TLR2 and TLR4 exhibited significantly increased 37 protein expression. Further, TLR2 and TLR4 inhibition by OxPAPC (1-palmitoyl-2-arachidonyl-38 sn-glycero-3-phosphorylcholine) impregnated hydrogels, resulted in a significantly increased rate 39 of wound healing in db/db mice via decreasing the significant levels of TNF-α and IL-1β. These 40 results show that increased TLR 2 and TLR 4 expression underlies delayed wound healing in 41 diabetes and a hydrogel impregnated with OxPAPC may be a promising therapeutic strategy for 42 the management of diabetic wounds. Our study goes closer in understanding the molecular 43 mechanism and provides a novel treatment method in diabetic wounds. 44 3 45 Introduction 46 Diabetes is afflicting nearly 422 million people worldwide[1] and its prevalence is associated with 47 increasing incidences of diabetes associated disorders. Type I and Type II diabetes both are marked 48 by increased inflammation as evidenced by increased monocyte activity[2][3]. Inflammation is the 49 key regulator in the diabetes-related disorders like delayed wound healing[4][5]. However, the 50 cause of this prolonged inflammation in diabetes and underlying mechanisms are yet unknown. 51 Therefore, a clearer understanding of the mechanisms underlying prolonged inflammation can be 52 the key to success for designing targeting drugs for control of inflammation in diabetes. 53 Toll-like receptors (TLRs) are highly conserved pattern recognition receptors (PRRs) expressed in 54 various cells involved in immune system like monocytes, neutrophils and macrophages[6], acting 55 as key players in inflammation. A number of germline encoding pattern recognition receptors 56 (PRRs) are known, of which, the TLR family is the major comprising of 13 members[7]. These 57 PRRs recognize the pathogen-associated molecular patterns (PAMPs) often associated with the 58 invading pathogens. Upon PAMPs recognition the PRRs trigger multitude intracellular signaling 59 pathways in the host involving the active participation of adapter molecules, kinases and various 60 transcription factors[8]. This process culminates with the activation of several cytokines, 61 chemokines, cell adhesion molecules and immunoreceptors[9]. However, these TLRs can also 62 recognize certain host factors as "threat signals" when they are present in the form of abnormal 63 molecular complexes produced as a result of cellular stress[10].
5 90 pig model [26] . It has been proved that the release of drug through TGMS is stimulus-dependent 91 i.e. in response to the severity of inflammation. Due to the stimulus dependent response, the graft 92 rejection could be prevented for >100 days compared to control animals. Hence, we chose TGMS- 93 hydrogel system to deliver TLR2 and4inducerLPS-Ek (lipopolysaccharide from E. coli K-12) and 94 inhibitor OxPAPC during the delayed wound repair/healing phases in diabetic animals. Our TGMS 95 based system would ensure the release of these molecules only during the inflammatory stimulus 96 along with a more localized delivery and minimal release in the absence of stimulus (i.e. enzymes). 97 Therefore, making TGMS a very efficient system for delivery of therapeutics in chronic non-98 healing wounds. Moreover, OxPAPC if given through a systemic route might lead to systemic 99 immune suppression and off-target effects. We have tried to avoid this problem by choosing a 100 localized delivery system. 101 Therefore, this study shows that an abnormality in TLR expression leads to delayed healing of 102 wounds in diabetes employing db/db mice model. Additionally, we have also shown that hydrogels 103 impregnated with TLR 2 and TLR 4 inducer and inhibitor could potentially treat the non-healing 104 diabetic wounds. All the experiments were performed on 5 to 6 weeks old female, inbred db/db mice on C57 BL/6J 113 background with average weight of 26±1 gram. These were obtained from National Institute of 114 Immunology (NII), New Delhi, India. The animals were maintained under controlled laboratory 115 conditions. All animal care and experimental procedures described in this study were specifically 116 approved by the Animal DMSO was added. The mixture was heated up to 60-70ᵒC to dissolve and allowed to stand. Upon 169 cooling, the mixture was re-heated to dissolve, and remaining amount of water was added to form 170 uniform solution which was taken into 1ml syringe and allowed to stand for 3-4 days before use 171 in animals. In the formulation of gels loaded with OxPAPC and LPS-Ek; 400µg/ml and 50µg/ml 172 of respective amounts were dissolved in 200µl of DMSO and formulated into 1ml gels as described The results of the RT-PCR from skin and wound tissues of db/db mice exhibited significantly 217 increased (p<0.001) TLRs (1, 2, 3, 4, 5, 6, 7, 9) Expression of TLR 2-9 were found significantly upregulated (p<0.001) in wound tissues of db/db 235 mice as compared to wild type control (Fig 3) . Gene expression of TLR increases in cultured primary macrophages 242 TLR1, TLR2 (p<0.05) and TLR4, TLR6, TLR7 (p<0.001) were only found upregulated in the 243 primary macrophages derived from wound tissues of db/db mice as compared to wild type (Fig 4) . Out of the all TLRs expressed at the transcription level in primary macrophages from db/db mice 252 only TLR2,4,6,7 were found to be significantly upregulated (p<0.001) at the protein level as well 253 (Fig 5) . This implicates that the TLR proteins are being expressed at the protein level at the wound 13 254 site where macrophages are attracted as a result of the injury. Probably, downstream signaling 255 from this increased level of TLR resulted into the enhanced production of inflammatory cytokines.
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This would further implicate that there could be an increased number of macrophages which could 257 result in the increased TLR 2,4,6,7 protein expression. of mice. However, the result was found to be less significant in all four groups of non-diabetic 291 mice (p>0.05) (Fig 7) . 
